GlassScriptPhysician profile
Jeremy S Pollock
NPI 1124310289
$80,072.82
in general payments reported to CMS, 2019-2025
40 companies · $1,398 in 2025
The $1,398 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $16K · 2021: $21K · 2022: $7,578 · 2023: $9,440 · 2024: $2,751 · 2025: $1,398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,940 · Food and Beverage: $5,620 · Travel and Lodging: $29.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,940.00 |
| Food and Beverage | $5,619.54 |
| Travel and Lodging | $29.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $42,897.94 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $20,579.89 | 2019-2023 | |
| Scpharmaceuticals INC. | $4,413.15 | 2023-2025 | |
| Lilly USA, LLC | $2,865.00 | 2020-2023 | Jardiance |
| Medtronic, INC. | $1,156.43 | 2021-2025 | Onyx Frontier, Symplicity G3, Micra |
| Pfizer INC. | $1,083.98 | 2019-2025 | |
| Edwards Lifesciences Corporation | $943.69 | 2019-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $786.83 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $740.79 | 2020-2025 | Eliquis, Camzyos |
| Amgen INC. | $710.83 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $545.81 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $499.76 | 2019-2024 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $293.63 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $270.70 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Esperion Therapeutics, INC. | $224.75 | 2020-2025 | Nexletol |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $219.33 | 2023-2025 | Onpattro, Amvuttra |
| Abbott Laboratories | $180.82 | 2022-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Assurity |
| Sanofi-Aventis U.S. LLC | $175.87 | 2019-2024 | |
| Atricure, INC. | $172.82 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $159.59 | 2023-2025 | Opsumit, Uptravi |
| Preventice Services, LLC | $132.34 | 2019 | |
| Irhythm Technologies, INC. | $117.82 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals, LTD. | $96.82 | 2022-2023 | Arcalyst |
| Philips North America LLC | $92.95 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Regeneron Healthcare Solutions, INC. | $90.93 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $78.39 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $65.94 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $63.24 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $60.85 | 2023-2024 | Watchman Access System, Resonate El Icd Vr |
| Gilead Sciences, INC. | $59.08 | 2019 | |
| Merck Sharp & Dohme LLC | $58.77 | 2023-2024 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $39.77 | 2020-2021 | |
| Braemar Manufacturing, LLC | $36.45 | 2019 | |
| Bardy Diagnostics, INC. | $33.79 | 2019 | |
| Cardiva Medical, INC. | $29.38 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Chiesi USA, INC. | $22.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.42 | 2023 | |
| Lantheus Medical Imaging, INC. | $19.99 | 2019 | |
| Biotronik INC. | $15.90 | 2021 | |
| Elutia, INC. | $15.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeremy Pollock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.